Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

News | Leads Implantable Devices

September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual Transcatheter ...

Home September 20, 2019
Home
News | Heart Failure

September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept. 30 ...

Home September 20, 2019
Home
News | Heart Failure

September 18, 2019 — AstraZeneca announced the U.S. Food and Drug Administration (FDA) has granted Fast Track ...

Home September 18, 2019
Home
Technology | Angiography

September 17, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Artis icono, a high-precision family of ...

Home September 17, 2019
Home
News | Ventricular Assist Devices (VAD)

September 12, 2019 — CorWave announced successful completion of its first 60-day preclinical study to evaluate its ...

Home September 12, 2019
Home
News | Heart Failure

September 12, 2019 — Corvia Medical has sponsored and is actively enrolling patients in a heart failure (HF) device ...

Home September 12, 2019
Home
Videos | Hemodynamic Support Devices

A discussion with William O'Neill, M.D., director of the structural heart program, Henry Ford Hospital, and Michele ...

Home September 12, 2019
Home
News | Heart Failure

September 11, 2019 — The ever-present devices that seem to track all our moves can be annoying, intrusive or worse, but ...

Home September 11, 2019
Home
News | Heart Failure

September 11, 2019 — The angiotensin neprilysin inhibitor sacubitril/valsartan (Entresto) missed its primary endpoint of ...

Home September 11, 2019
Home
News | Heart Failure

September 9, 2019 — AstraZeneca announced detailed results from the landmark Phase III DAPA-HF trial that showed Farxiga ...

Home September 09, 2019
Home
News | Cardiac Imaging

September 9, 2019 — The American Society of Nuclear Cardiology (ASNC) published a new expert consensus document along ...

Home September 09, 2019
Home
News | Heart Failure

September 9, 2019 — The drug Dapagliflozin was found to reduce death and hospitalization in patients who have heart ...

Home September 09, 2019
Home
News | Cardiovascular Business

September 6, 2019 — Business-to-business communications company Scranton Gillette Communications has named Diane ...

Home September 06, 2019
Home
News | Heart Valve Technology

September 5, 2019 — Abbott announced the launch of the company's TRILUMINATE Pivotal trial evaluating the safety and ...

Home September 05, 2019
Home
Subscribe Now